Observational Study
Copyright ©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 106967
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106967
Table 1 Characteristics of participants.
Characteristic
GDM
T2DM
P value
N89 (58.6%)63 (41.4%)-
Age (years)35.3 ± 3.835.6 ± 3.90.717
Age at diagnosis (years)35 (33-38)33 (29.5-36)0.002
Gestational age at first visit (weeks)29.3 (26.6-32.7)10.7 (8.1-16.7)< 0.001
Pre-pregnancy BMI (kg/m2)23.3 (20.4-25.8)25.1 (22.1-29.0)0.003
Gravidity2 (1-3)1 (1-2)0.04
Parity0 (0-1)0 (0-0)0.072
Mode of conception
Natural conception68 (76.4%)53 (84.1%)0.495
IVF-ET16 (18.0%)8 (12.7%)0.488
Ovulation induction by letrozole5 (5.6%)2 (3.2%)0.516
Singleton pregnancy83 (93.3%)62 (98.4%)0.24
Multiple pregnancy6 (6.7%)1 (1.6%)0.24
HbA1c (%)5.2 (5.0-5.5)5.3 (5.0-5.9)0.02
GA (%)13.3 (12.2-13.7)13.3 (12.6-14.6)0.364
Hemoglobin (g/L)125.7 ± 10.1124.9 ± 10.80.613
Serum iron (μg/dL)92.0 (75.5-116.0)108.0 (82-132)0.049
Serum ferritin (ng/mL)28.5 (16.0-52.8)53 (35-92)< 0.001
Serum vitamin B12 (pg/mL)312 (228-433)342 (281-476)0.072
Pharmacotherapy
Insulin50 (56.2%)40 (63.5%)0.012
Metformin0 (0%)1 (1.6%)0.349
Insulin and metformin0 (0%)8 (12.7%)< 0.001
CGM profiles2 (1-3)2 (1-6)0.063
CGM metrics
Number of days CGM worn (days)112.5 (11.3-12.8)12.9 (11.3-12.9)0.081
Percentage of time CGM is active (%)100 (100-100)100 (100-100)0.636
Mean glucose (mmol/L)5.5 (5.2-5.8)5.4 (5.0-5.9)0.214
Time in range (%) (3.5-7.8 mmol/L)93.4 (87.5-96.8)91.1 (84.7-95.4)0.001
Time above range (%) (> 7.8 mmol/L)3.9 (1.3-8.6)4.8 (1.6-10.7)0.045
Time below range (%) (< 3.5 mmol/L)0.7 (0.2-3.1)1.4 (0.2-4.3)0.021
Time below range (%) (< 3.0 mmol/L)0.1 (0-0.9)0.2 (0-1.1)0.215
Coefficient of variation (%)19.9 (17.5-23.1)21.9 (19.0-25.5)< 0.001